Improvement in results on a noninvasive urinary biomarker panel at 3 months among patients with lupus nephritis predicted a clinical response at 1 year. A noninvasive urinary biomarker panel predicts ...

Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...

WASHINGTON -- Lupus nephritis (LN) diagnosis could improve greatly if early results with a multimarker urine test are confirmed in larger studies, research presented here suggested. Measurement of 12 ...

Amit Saxena, MD, discusses how evidence-based guidelines from ACR and KDIGO have evolved to shape lupus nephritis treatment approaches, emphasizing their critical role in standardizing patient care ...

A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...

Circulating microRNAs as well as urinary extracellular vesicles plus cytokines potentially reflect lupus nephritis activity beyond traditional laboratory parameters. Circulating microRNAs (miRNAs) and ...

Roche Holding said the Food and Drug Administration approved a drug for the treatment of adults with lupus nephritis, a potentially life-threatening autoimmune disease that commonly affects the ...